These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combination chemotherapy with cyclophosphamide, vinblastine, procarbazine and prednisone in the treatment of malignant lymphomas. Host H, Abrahamsen AF. Scand J Haematol; 1973 Mar; 10(3):170-6. PubMed ID: 4588616 [No Abstract] [Full Text] [Related]
4. [Personal experience on the chemotherapy of leukemias and hematosarcomas]. Mathé G, Schneider M, Schwarzenberg L, Cattan A, Amiel JL, Schlumberger JR. Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537 [No Abstract] [Full Text] [Related]
5. Recent advances in chemotherapy of lymphoma. Lenhard RE, Owens AH. Johns Hopkins Med J; 1967 Aug; 121(2):136-40. PubMed ID: 5340335 [No Abstract] [Full Text] [Related]
6. [Natulan (experimental and clinical data on its antitumor effect)]. Brodskaia NA. Vopr Onkol; 1972 Aug; 18(11):101-9. PubMed ID: 4566561 [No Abstract] [Full Text] [Related]
7. [Hodgkin's disease in children. Study of 72 personal cases]. Teillet F, Schweisguth O. Arch Fr Pediatr; 1968 Mar; 25(3):313-30. PubMed ID: 5670329 [No Abstract] [Full Text] [Related]
8. [Treatment of systemic hemolymphopathies and of epithelial and connective-tissue neoplasms with a methylhydrazine derivative]. Zarrilli D, Perrone V, Pergola M. Clin Ter; 1966 Oct 31; 39(2):123-36. PubMed ID: 4871417 [No Abstract] [Full Text] [Related]
10. Vinblastine treatment of malignant lymphomas. Klener P, Donner L, Neuwirtová R, Ort J. Neoplasma; 1971 Oct 31; 18(5):505-11. PubMed ID: 4940935 [No Abstract] [Full Text] [Related]
11. Mechlorethamine HCl and cyclophosphamide in the treatment of Hodgkin's disease and the lymphomas. Jacobs EM, Peters FC, Luce JK, Zippin C, Wood DA. JAMA; 1968 Feb 05; 203(6):392-8. PubMed ID: 4865234 [No Abstract] [Full Text] [Related]
12. Current problems in the use of the oncolytic drugs. Armstrong JG. Acta Genet Med Gemellol (Roma); 1968 Jan 05; 17(1):270-7. PubMed ID: 4298202 [No Abstract] [Full Text] [Related]
13. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy]. Danieli G. G Clin Med; 1966 Aug 05; 47(8):732-68. PubMed ID: 4865460 [No Abstract] [Full Text] [Related]
14. Use of vinblastine for maintenance therapy in malignant lymphomas. Klener P, Donner L, Ort J. Neoplasma; 1974 Aug 05; 21(3):323-9. PubMed ID: 4608740 [No Abstract] [Full Text] [Related]
15. Initial experiences with methylhydrazine, a new cytotoxic agent. Backhouse TW, Sicher K. Clin Radiol; 1966 Apr 05; 17(2):132-5. PubMed ID: 5952323 [No Abstract] [Full Text] [Related]
16. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas]. Klein HO. Hamatol Bluttransfus; 1976 Apr 05; 18():135-45. PubMed ID: 786808 [No Abstract] [Full Text] [Related]
17. Treatment of histiocytic lymphoma in Uganda adults. Olweny CL, Ziegler JL. East Afr Med J; 1971 Oct 05; 48(10):585-91. PubMed ID: 4946665 [No Abstract] [Full Text] [Related]
18. The effects of two alkaloids derived from Vinca rosea on the malignant cells of Hodgkin's disease, lymphosarcoma and acute leukemia in vivo. Marmont AM, Damasio EE. Blood; 1967 Jan 05; 29(1):1-21. PubMed ID: 5334796 [No Abstract] [Full Text] [Related]
20. How to use cancer chemotherapy. Dollinger MR. Am Fam Physician; 1971 Jun 05; 3(6):73-84. PubMed ID: 4325596 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]